A carregar...
One-year outcomes of ziv-aflibercept for macular edema in central retinal vein occlusion
PURPOSE: To report the 12-month efficacy and safety outcomes of intravitreal ziv-aflibercept in macular edema secondary to central retinal vein occlusion (CRVO). METHODS: Interventional case series documenting 12-month outcomes of intravitreal ziv-aflibercept (1.25 mg in 0.05 mL) in 6 patients with...
Na minha lista:
| Publicado no: | Am J Ophthalmol Case Rep |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5731707/ https://ncbi.nlm.nih.gov/pubmed/29260119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajoc.2017.10.011 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
A carregar...